











































Aging is usually accompanied by diseases like 
cardiovascular dysfunctions or cancer [1], indicating 
that they are caused by related molecular processes [2-
4]. A mechanism recognized to contribute to many 
aging processes and accompanying diseases is the 
accumulation of damage caused by reactive oxygen 
species (ROS) [5, 6], which are mainly formed by the 
mitochondrial respiratory chain. Aging tissues exhibit 
elevated levels of oxidized lipids and proteins  [5]  and  
 
 




















































































show increased expression of stress response genes [7]. 
Consistently, lifespan extension through Sirtuin 
activation or caloric restriction appears to be due to an 
increase of stress resistance and the alleviation of 
diseases [6, 8, 9]. 
 
Under normal conditions, overall cellular ROS levels 
are kept low by antioxidants, such as glutathione 
(GSH). Besides their destructive role, however, ROS 
also act as signaling mediators [10, 11]. They can,  e.g., 
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mitochondrial membranes [12], resulting in cytochrome 
c (Cyt c) release and apoptosome activation [13]. ROS 
can represent oxidative stress upstream of this step, but 
cellular ROS levels can also be actively increased after 
pro-apoptotic stimuli [6]. ROS can thus establish a 
positive feedback loop, as described for the oxidant-
induced activation of p53 that leads to ROS formation 
[6, 14, 15]. Consistently, antioxidant treatment protects 
cells from apoptosis not only if initiated by oxidants, 
but also if initiated by a wide variety of stressors and 
stimuli [16].  
 
p66Shc appears to be a central player in stress-induced 
apoptosis and ROS amplification, in diseases caused by 
dysfunction of this system, and in life-span regulation 
[17, 18]. Knocking out the shcA (Src homologous and 
collagen A) gene coding for p66Shc results in decreased 
ROS levels and a 30 % extended lifespan of rodents 
[19]. p66Shc has been implicated in promoting cancer 
cell growth and in aging-associated arterial dysfunctions 
[2, 20], and has thus been suggested as a novel drug 
target [21]. p66Shc is the largest polypeptide encoded 
by the shcA locus, besides p46Shc and p52Shc. All 
isoforms share a phosphotyrosine-binding (PTB), a 
collagen homology (CH), and a Src homology 2 (SH2) 
domain; p52Shc shares an additional Cytochrome c 
binding domain (CB) with p66Shc, which carries a 
unique CH2 domain at its N-terminus. The mainly 
cytosolic isoforms p46Shc and p52Shc act as adaptor 
proteins regulating, e.g., elements of the Ras signaling 
pathway [18]. In contrast, p66Shc is located in the 
cytosol and the mitochondrial intermembrane space 
(IMS) [22-24]. Upon induction by stress factors, 
expression of the p66Shc protein increases [25], 
existing p66Shc is stabilized [26], and cytosolic p66Shc 
gets phosphorylated by protein kinase Cβ (PKCβ￿, 
followed by an interaction with the prolyl isomerase 
Pin1 and translocation to the IMS [24]. In this study, 
p66Shc has been suggested to directly form H2O2 [22], 
which is assumed to activate the permeability transition 
pore (PTP), ultimately causing rupture of mitochondria. 
Consistently, overexpression of p66Shc increases ROS 
level [27] and p66Shc-/- fibroblasts are resistant to 
apoptosis induced by several stressors [19, 28, 29]. 
Thus, p66Shc acts as sensor for ROS, but also for other 
stress factors, and on the other hand increases ROS 
formation leading to apoptosis initiation, presumably 
under overwhelming stress when repair systems cannot 
cope with the ROS anymore. However, the N-terminal 
p66Shc domain responsible for apoptosis induction and 
H2O2 formation could be shown to be a better apoptosis 
inducer in an oxidized, tetrameric form, but to produce 
more ROS in its reduced, dimeric form [30], indicating 
that the molecular details of p66Shc-mediated apoptosis 
are still not fully understood. 
 
We showed previously that p66Shc can interact with 
thioredoxins (Trx), which reduce and thereby inactivate 
the N-terminal domains, CH2 and CB (p66CH2CB), 
that carry the apoptosis inducing and H2O2-forming 
activity of p66Shc [30]. Another prominent family of 
proteins contributing to redox metabolism and signaling 
are peroxiredoxins (Prx) [31]. Prx degrade H2O2 using a 
conserved cysteine residue. Mammals have six 
isoforms, Prx1-6, divided into classes depending on 
whether they exhibit just the catalytic (peroxidasic) 
cysteine or also an additional, resolving cysteine, and 
whether both cysteines are on the same polypeptide 
[32]. Prx are weak scavengers, but due to their 
abundance and broad substrate specificity they 
effectively degrade peroxides at low concentrations. 
Increased H2O2 levels, in contrast, inactivate Prx 
through overoxidation of the peroxidasic cysteine, 
making them ideal sensors for H2O2-mediated signaling 
[31]. Many Prx further exist in different oligomeric 
forms, a dimeric form with significant peroxidase 
activity, which was proposed to be stabilized by 
oxidation at the catalytic cysteine, and an oligomeric 
form with low peroxidase activity that appears to act as 
chaperone. Furthermore, Prx can interact with other 
proteins apparently for regulating their activity [31], 
such as the inhibitory interaction of Prx1 with the 
apoptosis signal-regulating kinase 1 (Ask1) [33].  
 
Here, we describe the identification of Prx1 as a novel 
interaction partner for the unique N-terminal domain of 
p66Shc, and the biochemical characterization of this 
complex. Prx1 was identified in affinity experiments as 
dominant interaction partner. Complex formation leads 
to disassembly of the decameric form of Prx1, which is 
known to increase its peroxidase activity. The 
interaction leads to reduction of the p66CH2CB 
tetramer, which reduces its ability to induce 
mitochondrial rupture. These results indicate that 
p66CH2CB and Prx1 form a stress-sensing complex 





p66Shc regulation through phosphorylation and 
interaction with Pin1 
 
Cells need to have mechanisms strictly silencing the 
cytotoxic activities of p66Shc, ROS-generation and 
apoptosis-induction, during cell cycle but stimulating 
them during cellular stress. PKCβ and the peptidyl-
prolyl isomerase Pin1 have been reported to regulate the  
 
   















































































































   
www.impactaging.com                  256                                AGING, February 2009, Vol.1 No.2relocalization of p66Shc to mitochondria required for 
apoptosis initiation. PKCβ phosphorylates p66Shc at 
Ser36 in response to oxidative stress [19], which was 
reported already to increase cellular ROS levels [24]. 
We tested whether phosphorylation leads to a direct 
stimulation of the p66Shc-inherent oxidoreductase 
activity. We simulated phosphorylation by mutating 















































generating activity of the Ser36Asp mutant to wildtype 
(WT) protein in a fluorescence-based H2O2 assay (Figure  
1a). The p66CH2CB-Ser36Asp mutant displayed a 
significantly increased activity compared to WT protein, 
independent of the dimer/tetramer equilibrium (data not 
shown) that is known to influence ROS formation [30], 
showing that phosphorylation at Ser36 indeed directly 








































(b‐d)  p66CH2CB  interacts  with  dimeric  and  decameric  Prx1  in  a  1:1  stoichiometry  and  perturbs  its  decameric  arrangement.  20  µg
p66CH2CB WT (b) or p66CH2CB‐Cys59Ser (c) were incubated with 40 µg Prx1 WT or 20 µg Prx1‐Cys83Ser, respectively, for 1 hour at room
temperature and subjected to BN‐PAGE (b+c). Lanes 1 and 2 from (b) are repeated in (c) for clarity. The p66CH2CB‐Cys59Ser/Prx1‐
Cys83Ser  interaction  complex  is  marked  by  an  arrow.  (d)  Bands  labelled  1‐7  in  panel  (b)  were  subjected  to  a  second  separation
dimension, denaturing SDS‐PAGE.  
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but also induces an interaction with Pin1, assumed to 
lead to a peptidyl cis-trans isomerisation, which was 
reported to stimulate translocation of p66Shc
 into the 
mitochondrial IMS [24]. We aimed to test whether the 
suggested peptide cis-trans isomerisation influences the 
ROS-forming activity of p66Shc. Indeed, addition of 
Pin1 to the fluorescence-based assay inhibited ROS-
production by p66CH2CB-Ser36Asp, but only in a 
stoichiometry of about 1:1 p66CH2CB (Figure 1b). 
Catalytic Pin1 amounts (e.g. 1:100 Pin1:p66CH2CB-
Ser36Asp) had no significant effect, suggesting that the 
interaction leads to complex formation rather than an 
enzymatic isomerisation of p66CH2CB-Ser36Asp. 
Consistently, addition of the dipeptide Ala-Pro, a 
known inhibitor of Pin1-induced isomerization, had no 
effect on the Pin1-dependent quenching of p66CH2CB-
dependent ROS production (Figure 1c). 
 
We next tested the effects of Ser36 phosphorylation and 
Pin1 binding in a mitochondrial swelling assay. Both 
oligomeric forms of p66CH2CB-Ser36Asp, dimer and 
tetramer, hardly induced rupture of mitochondria, in 
contrast to the active WT form, the tetramer (Figure 
1d). This observation is consistent with the suggested 
necessity of Ser36 dephosphorylation, after interaction 
with Pin1, for enabling the proapoptotic function of 
p66Shc [24]. Adding Pin1 to p66CH2CB-Ser36Asp had 
no further effect on the already low mitochondria 
swelling activity of the mutant (data not shown). We 
conclude that phosphorylation at Ser36, which appears 
necessary for initiating relocation to the IMS [24], 
increases the ROS-generating activity of p66Shc. This 
apparently unintentional increase can be compensated in 
the cytosol by complex formation with Pin1. Once 
p66Shc
 reaches the IMS, however, dephosphorylation is 
required to enable mitochondrial rupture. These results 
reinforce the notion that the ROS-forming and 
apoptosis-inducing activities of p66Shc are not directly 
coupled, and that the physiological functions and 
regulation of these activities will have to be further 
studied for a complete understanding of this signaling 
system. H2O2 could, e.g., be an intrinsically formed 
p66Shc activator, as H2O2 can induce formation of 
oxidized p66Shc (Figure 1e), or H2O2 formation might 
just be a side reaction of a different redox reaction 
catalyzed by p66Shc (see below). 
 
p66CH2CB physically interacts with Prx1 
 
In order to identify novel interaction partners of p66Shc 
contributing to its complex regulation and localization, 
we performed an in vivo pull down experiment using 
immobilized p66CH2CB (a mixture of dimeric and 
tetrameric state) and cleared mitochondrial lysate. Due 
to the lack of hypothesis which protein might interact 
with p66CH2CB, we could not use specific antibodies 
to analyze the pull down eluate. Instead, we used a mass 
spectrometry-based multidimensional protein 
identification technology (MudPIT) [34] which is able 
to analyze complex protein solutions. In order to 
exclude non-specifically bound proteins, hits also found 
in control experiments without immobilized protein or 
with the unrelated protein Sirtuin 5 (Sirt5) were 
removed. Additionally, we used the number of spectrum 
counts (total number of successful MS/MS spectra) [35] 
as well as the sequence coverage of the detected 
proteins as parameters to semi quantify their abundance 
in the eluate. Interestingly, Prx1 stands out with a very 
high number of spectrum counts (122) and very high 
sequence coverage (55.8 %) besides proteins only 
identified with very low values (Figure 2a). Much 
weaker signals, but still specifically only in the 
p66CH2CB sample, were observed for the previously 
described p66Shc interaction partner Hsp70 [28] and for 
Prx3, which was identified with a sequence coverage of 
8.9 % and 2 spectrum counts.  
 
Peroxiredoxines are highly abundant in cells. However, 
in contrast to other abundant proteins, like glutamate-
dehydrogenase 1 or catalase, which were found in all 
samples independent of presence and identity of an 
immobilized protein, Prx1 and Prx3 were exclusively 
detected in the p66CH2CB sample and not, e.g., in the 
Sirt5 control. To identify the p66Shc form which 
interacts with Prx1, we repeated the in vivo pull-down 
with the isolated dimeric state and the isolated 
tetrameric state of p66CH2CB. However, Prx1 was 
reproducibly found as dominant signal in both samples 
(data not shown) indicating that Prx1 might interact 
with both forms (see below). We conclude that Prx1 
was strongly enriched, and possibly Prx3 to a lower 
extent, through a specific interaction with the 
immobilized p66CH2CB. 
 
p66Shc disassembles the Prx1 decamer 
 
In order to confirm and to further characterize the 
complex of p66CH2CB and Prx1 we analyzed their 
interaction in BN-PAGE experiments using purified 
recombinant protein (Figure 2b, 2c). Prx1 is known to 
have two oligomeric states with different molecular 
functions: In its dimeric state it shows H2O2-degrading 
(peroxidase) activity, but switches to chaperone activity 
after formation of a decamer, consisting of five dimers, 
in response to heat stress or oxidative stress [36, 37]. On 
the BN-gel WT Prx1 mainly exists as a decamer (Figure 
2b, lane 1). However, in the presence of p66CH2CB the 
decameric Prx1 ring dissociates (Figure 2b, lane 4). The 
result is a ladder of bands  indicating  either active dis- 
   







































assembly of Prx1 decamers by p66CH2CB or 
p66CH2CB-dependent stabilization of spontaneously 
disassembled Prx1 forms preventing instantaneous 
reassembly of the decamer. 
 
The still not fully understood system of different 
oligomeric Prx forms, likely corresponding to different 
activities (dimer: peroxidase; decamer: chaperone) is 
influenced by two catalytic and one regulatory Cys 
residue. H2O2-degradation is accomplished through 
oxidation of the peroxidasic cysteine (Cys52 in mouse 
Prx1) by H2O2 into a sulphenic acid. This residue then 
forms an intermolecular disulfide with the resolving 
cysteine (Cys173 in mouse Prx1) of the second 
monomer within dimeric peroxiredoxins. Finally, Trx 

















































Likewise, p66CH2CB reversibly forms tetramers by 
disulfide bridging [30] and we observed that these 
disulfides can be exchanged with reduced Prx1 (see 
below), leading to disulfide-linked Prx1 monomers 
similarly to H2O2-dependent oxidation. The upper bands 
of the ladder in the BN-gel obtained in the presence of 
p66Shc might therefore be higher oligomeric complexes 
which are stabilized by disulfide-bridging of Prx1 
molecules. In agreement, incubation of the decameric 
Prx1 with the p66CH2CB Cys59Ser mutant, which 
lacks the redox-active cysteine residue and therefore 
cannot oxidize Prx1, does not result in the ladder of 
bands. Instead, one dominant band above 100 kDa 
appears in the BN-gel (Figure 2c, lane 4). Furthermore, 
incubation of p66CH2CB WT or p66CH2CB-Cys59Ser 
with Prx1-Cys83Ser, a Cys83Ser regulatory mutant that 
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dimer, also results in this dominant band (Figure 2b, 2c, 
lane 5). This finding indicates that the Prx1 dimer might 
be the primary interaction partner for p66Shc. 
 
The question arises whether the various bands all 
contain complexes or instead only consist of Prx1 
oligomers. In order to identify the content of the bands, 
we separated their content in a second, denaturing gel 
electrophoresis dimension (Figure 2d). Bands 1-5 and 7 
comprise both proteins, Prx1 as well as p66CH2CB, 
again proofing their interaction (Figure 2d, lane 1-5 and 
7) and indicating that various complex oligomers can be 
formed. Band 6 of the Prx1 control, which has roughly 
the same size in the BN-gel as band 7 (Figure 2b), as 
expected only produced a Prx1 band in the denaturing 






































and 7 appeared in about equal amounts on the SDS-gel, 
which indicates an interaction stoichiometry of 1:1. 
Contrary, bands 4 and 5 mainly consist of p66Shc 
(Figure 2d, lane 4 & 5). However, they are very close to 
the band of tetrameric p66Shc, which likely 
contaminates the complex bands and artificially 
influences the protein ratio. We conclude that 
p66CH2CB and Prx1 indeed interact physically, 
apparently in a stoichiometry of 1:1, and that this inter-
action promotes disassembly of the decameric 
(chaperone) form of Prx1. Our findings render the 
dimeric Prx1 form the most likely interaction partner of 
p66CH2CB. Furthermore, p66CH2CB/Prx1 complex 
formation does not dependent on disulfide-bridging 
between Prx1 and p66CH2CB, but disulfide-bonds 
between Prx1 monomers can lead to formation of higher 

































Pin1,  which  also  leads  to  p66Shc  translocation  to  the  mitochondrial  IMS.  Here,  tetrameric  p66Shc  is  formed  which  finally  induces
apoptosis by initiating mitochondrial rupture through a still not fully understood mechanism, possibly involving its ROS‐forming activity.  
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p66Shc is known to generate H2O2 whereas 
peroxiredoxins exhibit weak but significant peroxidase 
activity. We therefore hypothized that Prx1 might 
degrade p66Shc-generated H2O2 and thereby inhibit 
p66Shc-dependent apoptosis. The other way round, 
p66Shc might inactivate Prx1 so that formed H2O2 does 
not get inactivated. In order to test this hypothesis, we 
analyzed the Prx1 forms in degrading H2O2 in a 
fluorescence-based ROS assay. While Prx1 WT 
decreased the fluorescence signal of 0.005 % H2O2 only 
slightly, the dimeric Prx1-Cys83Ser mutant 
significantly degraded H2O2 (Figure 3a). This result is 
consistent with published findings that dimeric Prx1 
exhibits significant peroxidase activity, while the 
decameric form acts as a chaperone with decreased 
peroxidase activity [36, 37]. As a control we generated 
a peroxidase-inactive Prx1 mutant by exchanging the 
peroxidasic cysteine residue Cys52 against Ser. As 
expected, this inactive mutant Prx1-Cys52Ser had no 
effect in the fluorescence-based ROS assay (Figure 3a). 
 
Unfortunately, Prx1 peroxidase activity is inhibited by 
copper (data not shown), while H2O2-generation by 
p66Shc is copper-dependent [22, 30]. Therefore, a 
measurement of the Prx1 effect on ROS-generation by 
p66CH2CB was not possible. However, we observed a 
dramatic increase in fluorescence at 0.005 % H2O2 in 
the presence of p66CH2CB without copper (Figure 3b), 
indicating an additional, copper-independent activity of 
p66CH2CB converting H2O2 to another ROS species. 
This copper-independent p66CH2CB activity was 
inhibited by Prx1 WT and the constitutively dimeric 
(peroxidasic) Prx1-Cys83Ser mutant (Figure 3b). 
Interestingly, the same effect was observed using the 
peroxidase-inactive Prx1-Cys52Ser mutant, strongly 
indicating that H2O2 degradation by Prx1 is not 
involved in this inhibitory effect. Our results indicate 
that p66CH2CB has an unexplored, copper-independent 
redox activity, which is inhibited by Prx1 independent 
of its peroxidasic activity.  
 
We next tried to test the effect of the Prx1-dependent 
inhibition of p66CH2CB redox activity in an apoptosis 
induction assay using isolated mitochondria. Using a 4-
fold excess of Prx1 over p66CH2CB to ensure sufficient 
complex formation, however, induced mitochondrial 
rupture even in absence of p66CH2CB (data not shown), 
making this assay incompatible with Prx1. Our results 
suggest to analyze the copper-independent p66Shc 
activity further in future studies employing other 
techniques, most importantly in vivo experiments, which 
promises exciting new insights into the physiological 
mechanisms of p66Shc-mediated redox signaling. 
 
Disulfide exchange between p66CH2CB and Prx1 
 
We previously showed that the apoptosis inducing 
activity of p66CH2CB is activated by a reversible, 
oxidative dimer-tetramer transition, similar to regulation 
of Prx activity through disulfide-bridging. We therefore 
tested whether p66CH2CB and Prx1 influence the redox 
state of each other. The different states of p66CH2CB 
and Prx1 were detected by non-reducing SDS-PAGE: 
The denatured reduced forms run as monomers whereas 
the disulfide-linked forms behave as dimers (Figure 3c). 
After incubation of p66CH2CB with Prx1 WT, the 
reduced fraction of p66CH2CB is significantly 
increased whereas the reduced form of Prx1 WT 
decreases to a similar extent (Figure 3c). We therefore 
conclude that a reciprocal, thiol-based redox exchange 
reaction between oxidized, disulfide-bridged 
p66CH2CB and reduced Prx1 can occur. This redox 
reaction yields oxidized Prx1 and thus favors formation 
of dimeric, peroxidasic Prx1, consistent with our results 
of the BN-PAGE experiments (Figure 2b, 2c). At the 
same time, it yields reduced, dimeric p66CH2CB, 
which we previously showed to be an inactive form 
with respect to apoptosis induction. It thus appears that 
the p66Shc/Prx1 complex acts as an H2O2 degradation 
and sensing complex at low ROS levels, silencing the 
apoptotic function of p66Shc. At higher levels, Prx1 
becomes overoxidized, peroxidase inactive, and 
stabilized in the decameric form, which should favour 
p66Shc release and tetramerization, and thus apoptosis 
induction.  
 
To gain first insights into the dynamic composition and 
architecture of the p66Shc-based sensing complex, we 
tested whether the interaction of p66CH2CB with Trx 
influences complex formation with Prx1. We showed 
previously that Trx reduce and thus inactivate 
tetrameric p66CH2CB [30]. To avoid formation of 
mixed disulfides between Prx1 and Trx1 we used the 
Prx1-Cys52Ser active site mutant, which can still 
interact with p66CH2CB (see above). Adding Trx1 to 
p66CH2CB either before or during complex formation 
with Prx1-Cys52Ser did not prevent formation of the 
main complex band, but suppressed the weaker bands 
that appear to be caused by formation of further 
complexes through non-specific disulfide bonds (Figure  
3d). It thus appears that Prx1 uses a different binding 
site on p66Shc than Trx. Furthermore, the major 
complex band appears to be the only significant form of 
the p66Shc/Prx1 complex, as the other forms are likely 
to be resolved in vivo by the Trx system. 
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p66Shc is a key player in stress sensing and the stress-
induced mitochondrial apoptosis pathway. It acts as 
both, stress sensor and inducer of ROS formation, in a 
complex regulatory circuit [18, 38]. Despite a wealth of 
in vivo observations, several molecular mechanisms 
connecting p66Shc and other players of this network 
remain to be fully understood, such as the exact 
mechanism of p66Shc-dependent ROS generation and 
the mechanism of ROS-dependent permeability 
transition. Such an understanding would also support 
efforts to exploit p66Shc as a therapeutic target. We 
reasoned that identifying novel interaction partners of 
the p66Shc-specific N-terminal domain could reveal 
insights into the regulation of its deadly activity. We 
could indeed show here that p66CH2CB interacts with 
the peroxiredoxin family of antioxidant enzymes that 
also contribute to signal transduction, e.g., of the p38 
protein kinase [31, 39]. In particular, our results show 
that p66Shc can interact with Prx1, and possibly with 
Prx3, in a physiological environment and in vitro. We 
observed a dominant enrichment of Prx1 in affinity 
experiments, and a much weaker signal from Prx3 as 
well as the characterized p66Shc interaction partner 
Hsp70 [28], highlighting the value of our mass 
spectrometry approach which allowed the identification 
of an unexpected and dominant but so far overlooked 
interaction partner.  
 
Prx can act as H2O2 scavengers, but many studies have 
shown that they are also major contributors to a 
complex ROS signaling system [31, 40], most 
prominently in apoptosis initiation [41-43]. A Prx3 
knock-down shows increased sensitivity to apoptosis 
inducing signals [44], and Prx1 is involved in signaling 
by the p38 kinase [39] and acts as tumor suppressor [45, 
46]. Prx1 is mainly found in the cytosol, although a 
recent determination of the mitochondrial proteome also 
identified Prx1 in this organelle [47]. The fact that Prx1 
was more prominent in affinity experiment eluates than 
Prx3 even when mitochondrial lysates were used, which 
should contain more Prx3, indicates a pronounced 
preference of p66Shc for the Prx1 isoform. In fact, Prx3 
is mainly located in the mitochondrial matrix, whereas 
the mitochondrial IMS, where p66Shc appears to induce 
apoptosis [22], is generally assumed to be strongly 
connected to the cytosol. Thus, Prx1 appears to be the 
major isoform encountered by p66Shc and seems to be 
bound preferentially, even in presence of other 
peroxiredoxins, indicating a pronounced level of 
specificity for this interaction. The fact that even a 
cysteine-lacking mutant of p66CH2CB could bind to 
Prx1 and disassembles its decamer form also reinforces 
the notion that the interaction is rather specific and does 
not resemble the redox interactions often encountered 
with thioredoxins, which appear to keep surface 
cysteines of cellular proteins reduced with little 
specificity. However, the observation that Prx1 reduces 
and thereby inactivates p66CH2CB indicates that Prx1 
might functionally act like a Trx in this system. 
Protein/protein interactions have been described for Prx 
and are assumed to contribute to their function, in 
addition to H2O2 scavenging [31]. A regulatory role for 
an interaction with Prx1 has been described before for 
Ask1 [33], for example. In this system, the interaction 
rather than a redox reaction with Ask1 appears to be 
relevant for the apoptosis inhibiting effect of complex 
formation. It remains to be shown for the p66Shc/Prx1 
complex whether purely forming the interaction, or the 
reciprocal reduction/oxidation, or both processes are 
relevant for its physiological function. At present we 
hypothize that both elements contribute to making this 
complex of two intrinsic ROS sensors [30, 31] a highly 
regulated ROS sensing system (Figure 4): Complex 
formation keeps both players close in space, able to 
exchange information. The Prx, an efficient H2O2 
scavenger at low concentrations [31], will protect cells 
from moderate oxidative stress, from external sources or 
formed by p66Shc. It will thereby keep p66Shc reduced 
and unable to induce apoptosis. The peroxidase activity 
of Prx1 will be inactivated through overoxidation, 
however, if excessive oxidative stress is encountered. 
This szenario would favor Prx1 decamerization, p66Shc 
release and oxidation as well as release of additional 
ROS by p66Shc now lacking its ROS-scavenging 
partner. This change will finally lead to the ultimate 
cellular stress response to overwhelming stress, 
apoptosis induction. 
 
Prx show a versatile quaternary structure, apparently 
corresponding to different activities and or activation 
states [32, 48]. Two interaction interfaces of a Prx 
monomer contribute to oligomerization of Prx of the A-
type, which comprises mammalian Prx1 and Prx3 [32]. 
The first one is oriented parallel to the central β-sheet 
and mediates formation of a Prx1 dimer as its stable 
building block. A second one is oriented perpendicular 
to the central β-sheet and enables higher 
oligomerization of dimers. A “fully folded” confor-
mation of the peroxidasic cysteine loop is observed in 
the reduced Prx1 form and stabilizes the perpendicular 
interface, promoting oligomerization. The “locally 
unfolded” conformation of the oxidized form 
destabilizes this interface and thus the decamer. The 
disassembling effect of p66CH2CB on Prx1 even in 
absence of the p66Shc Cys, and thus thiol redox 
reactions, suggest this interface as likely binding site for 
p66Shc with a direct communication contact to the Prx 
active site (Figure 4). Our results with added Trx 
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further interactions, enabling formation of various 
complex forms, which can be reduced by Trx either 
through reduction or competition. The Prx1 binding 
site, however, does not serve as Trx binding site. The 
exact architecture of the p66Shc complexes formed with 
Prx1, however, will require future structural studies. 
 
Another protein contributing to p66Shc regulation is 
Pin1 [24], a phosphoSer/Thr-Pro recognizing protein 
that can catalyze cis-trans isomerization within this 
motif. Pin1 has previously been implicated in aging 
processes and cellular stress responses [49], and the 
interaction with p66Shc is likely to be a mechanism 
contributing to these effects. Pin1 can bind to proteins 
and influence their stability, for example to p53 and 
cyclin D1 [49-52]. Pin1 has been reported to bind to 
phosphorylated p66Shc prior to transport into the IMS 
[24]. Our results indicate that Pin1 might act in the 
p66Shc system as a cytosolic inactivator, or stabilizer of 
a redox inactive p66Shc form (Figure 4). The exact 
nature of the p66CH2CB-dependent H2O2-metabolizing 
redox activity that can be silenced by Pin1 remains to be 
revealed. It might help to understand the discrepancy 
between p66Shc’s apoptosis induction activity and its 
previously reported redox activity, H2O2 formation [22, 
30]. However, Pin1 was reported to be inactivated by 
oxidative stress [49, 53], which would be consistent 
with an p66Shc-inhibiting function. Excessive cellular 
stress leading to Pin1 inactivation would promote the 
cytotoxic effect of p66Shc by allowing IMS localization 
and ROS formation.  
 
Our results revealed novel regulatory effects and 
interactions within a p66Shc-centered signaling 
network. They should stimulate future studies on 
characterizing the coordination of these mechanisms in 
vivo and on the molecular architecture of the complexes 
formed by p66Shc. Such studies should lead to a further 
refined understanding of this complex signaling system, 
which should eventually enable development of drugs 
exploiting these mechanisms and interactions. 
 
MATERIALS AND METHODS 
 
Cloning and protein purification. Cloning of full length 
p66Shc and of residues 1-150 (p66CH2CB) were 
described previously [30]. The gene for Prx1 was PCR-
amplified from mouse colon cDNA and cloned into 
pET151/D-Topo (Invitrogen), resulting in a construct 
with an N-terminal 6x His-tag. Site-directed 
mutagenesis of p66CH2CB and Prx1 was done using 
the QuickChange protocol (Stratagene). Expression of 
WT proteins and variants was done as described for 
p66CH2CB [30]. Shortly, proteins were expressed in E. 
coli BL21(DE3)Rosetta2 cells cultured at 37 °C until 
the OD600 reached 0.6. Protein expression was induced 
by using 0.5 mM isopropyl β-D-thiogalactosid and cell 
culturing continued for 18 h at 20 °C. Harvested cells 
were disrupted using a French Press, and cell debris was 
removed by centrifugation (45 min at 18000 rpm, 
HFA22.50 rotor). Affinity chromatography was done 
with Talon resin (Clontech) (washing buffer 1: 20 mM 
Tris pH 7.8 + 500 mM NaCl; washing buffer 2: buffer 
A (20 mM Tris pH 7.8 + 150 mM NaCl) + 20 mM 
imidazole; elution buffer: buffer A + 100 mM 
imidazole). The proteins and their different oligomeric 
states were then further purified by size exclusion 
chromatography using a superose 12 column (GE 
Healthcare) in buffer A. 
 
Non-reducing SDS-PAGE, blue-native (BN)-PAGE and 
2D-PAGE.  SDS-PAGE was performed according to 
Laemmli et al. [54] with a T=15 % separating gel. The 
samples were incubated with loading buffer devoid of 
reducing agents for 5 min at 95 °C. BN-PAGE 
according to Schaegger et al. [55] was performed using 
a separating gel consisting of a T=10 % and a T=14 % 
layer overlaid with a 5 % stacking gel. The samples 
were supplied with 10 % (v/v) Glycerol instead of 
sample buffer. In order to run a second, denaturing 
dimension of the natively separated complexes, the 
respective gel bands were cut out of the BN-gel and 
equilibrated  with 1 % (w/v) SDS and 1 % (v/v) β-
mercaptoethanol first for 20 min at room temperature 
and second for 10 minutes at 50 °C. Subsequently, the 
gel pieces were washed extensively with distilled water 
and finally embedded into a SDS-PAGE stacking gel.  
 
Mitochondria swelling assay and fluorescence-based 
ROS assay.  Rat liver mitochondria were prepared 
freshly before use [30]. Swelling and rupture of 
mitochondria pretreated with 7 µM CaCl2 was 
monitored photometrically as a decrease of the OD620 as 
described previously [22]. The ROS-generating activity 
of p66CH2CB was measured using H2DDFDA 
(Invitrogen). For details see [22]. Changes in 
fluorescence (λ(ex)=498 nm, λ(em)=525 nm) of 10 µM 
H2DDFDA in 100 µl buffer A were recorded using a 
Perkin Elmer LS50B spectrofluorimeter. 
 
Pull-down experiment and MudPIT analysis. 40 µl of 
Talon resin were saturated by incubation with 400 µg of 
His-tagged protein in the presence of 10 mM imidazole 
for 30 min at room temperature. Mitochondrial lysate (3 
mg total mitochondrial protein) was added and 
incubated in the presence of 10 mM imidazole for 1 h at 
room temperature. The supernatant was removed and 
the affinity material first washed twice with washing 
buffer 1, and then twice with washing buffer 2. Finally, 
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elution buffer. Trypsin (Promega) was added to the 
eluate in a ratio of 1:100 and the proteins digested at 
37 °C over night. Digestion was stopped with 0.25 % 
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